TTUHSC School of Medicine
HomeSchool of MedicineContinuing Medical EducationGrand Rounds

Continuing Medical Education

Grand Rounds Detail

Recent Advances in the Management of Breast Cancer
5/8/2013
Speaker: Brian Pruitt, MD

Department: Internal MedicineRoom: TTUHSC SOP Auditorium
Directly Sponsored: Texas Tech University Health Sciences Center
Time: 12:00 pm to 1:00 pm
Campus: Amarillo


Click to Request More Information

Upon the completion of this activity the participant should be able to:
  • Describe briefly how aromatase inhibitors decrease estrogen levels in postmenopausal women.
  • Identify an mTOR inhibitor that can augment the effectiveness of an aromatase inhibitor in breast cancer therapy.
  • State that pertuzumab is a monoclonal antibody that prevents dimerization in the HER2 protein.
Accreditation: Texas Tech University Health Sciences Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: Texas Tech University Health Sciences Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

©